Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission

Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters

(2023) Geraldine Nouailles et al.   Nature Microbiology

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children

(2022) Asmaa Hachim et al.   Nature Communications

SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity

(2022) Liying Wang et al.   JOURNAL OF CELL BIOLOGY

SARS‐CoV‐2 ORF10 antagonizes STING‐dependent interferon activation and autophagy

(2022) Lulu Han et al.   JOURNAL OF MEDICAL VIROLOGY

COVID‐19: Clinical status of vaccine development till date

(2022) Sunny Kumar et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression

(2022) Najla Arshad et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis

(2021) Bryan A. Johnson et al.   NATURE

Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes

(2021) Ziliang Zhou et al.   iScience

Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice

(2021) Jesus A. Silvas et al.   JOURNAL OF VIROLOGY

A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo

(2021) Kevin Chiem et al.   JOURNAL OF VIROLOGY

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy

(2021) Ying Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding

(2021) Jakob Trimpert et al.   Cell Reports

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

(2021) Maya Shemesh et al.   PLoS Pathogens

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic

(2021) Samir Andrade Mendonça et al.   npj Vaccines

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2

(2021) Benjamin Israelow et al.   Science Immunology

Advanced Materials for SARS‐CoV‐2 Vaccines

(2021) Moustafa T. Mabrouk et al.   ADVANCED MATERIALS

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza

(2021) Arnold S. Monto   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses

(2021) Chengjin Ye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

(2020) Sin Fun Sia et al.   NATURE

Seasonality of Respiratory Viral Infections

(2020) Miyu Moriyama et al.   Annual Review of Virology

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

(2020) Ahmed O. Hassan et al.   CELL

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

(2020) Yujie Ren et al.   Cellular & Molecular Immunology

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

(2020) Kizzmekia S. Corbett et al.   NATURE

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

(2020) Lisa A. Jackson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular Architecture of the SARS-CoV-2 Virus

(2020) Hangping Yao et al.   CELL

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

(2020) Emma S. Winkler et al.   NATURE IMMUNOLOGY

Characteristics of SARS-CoV-2 and COVID-19

(2020) Ben Hu et al.   NATURE REVIEWS MICROBIOLOGY

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

(2020) Cheryl Keech et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling

(2020) Lisa Miorin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome

(2020) Chengjin Ye et al.   mBio

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

(2020) Jun-Gyu Park et al.   JOURNAL OF VIROLOGICAL METHODS

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

(2020) Fatai S. Oladunni et al.   Nature Communications

Origin and evolution of pathogenic coronaviruses

(2018) Jie Cui et al.   NATURE REVIEWS MICROBIOLOGY

Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease

(2017) Alan D.T. Barrett   VACCINE

Quantitative Analysis of Histological Staining and Fluorescence Using ImageJ

(2014) Ellen C. Jensen   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff

(2012) Pablo Cingolani et al.   FLY

Fast gapped-read alignment with Bowtie 2

(2012) Ben Langmead et al.   NATURE METHODS

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

(2012) Andreas Wilm et al.   NUCLEIC ACIDS RESEARCH